Amy C Lee, MD
Neurology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A98828 · Current
Licensed to practise in California · since 2007 · expires 2027-02-28 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$138,832
Medicare paid this office $138,832 for 366 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Botox | 25 | $48,848 | None |
| Return visit (30+ min) | 170 | $33,364 | $114 |
| New patient visit (45+ min) | 77 | $10,295 | $134 |
| Long return visit (40+ min) | 37 | $6,926 | $161 |
| Short return visit (20+ min) | 62 | $5,329 | $76 |
See all 13 services
| Botox | 25 | $48,848 | None |
| Return visit (30+ min) | 170 | $33,364 | $114 |
| New patient visit (45+ min) | 77 | $10,295 | $134 |
| Long return visit (40+ min) | 37 | $6,926 | $161 |
| Short return visit (20+ min) | 62 | $5,329 | $76 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 12 | $4,244 | $141 |
| Muscle electrical test | 31 | $4,088 | $100 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 149 | $3,935 | $14 |
| Nerve test | 16 | $3,593 | $225 |
| New patient visit (60+ min) | 14 | $2,688 | $192 |
| Muscle electrical test | 19 | $1,854 | $66 |
| Nerve test | 13 | $1,833 | $131 |
| New patient visit (30+ min) | 11 | $982 | $89 |
Who their Medicare patients are
366 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 22% · Women 66% · Also on Medicaid 14% · Health risk score 1.13. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 65% · Diabetes 27% · Depression 27% · Dementia 23% · Coronary heart disease 21% · Chronic kidney disease 20% · Atrial fibrillation 17% · Stroke 16% · Cancer 14% · Heart failure 9% · COPD 8%.
The office billed $490,904, Medicare allowed $184,429 and paid $138,832; for 10,902 services of 30 kinds; $48,848 of it was for drugs given in the office and $89,985 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 366 | 10,902 | 77 | 1.13 | $490,904 | $138,832 |
| 2023 | 377 | 8,251 | 77 | 1.23 | $421,029 | $123,766 |
| 2022 | 372 | 10,096 | 77 | 1.27 | $445,022 | $133,720 |
| 2021 | 373 | 10,599 | 76 | 1.30 | $447,943 | $140,991 |
| 2020 | 344 | 9,693 | 76 | 1.34 | $355,497 | $107,351 |
| 2019 | 439 | 12,619 | 76 | 1.30 | $489,480 | $140,103 |
| 2018 | 440 | 13,995 | 76 | 1.35 | $502,059 | $144,868 |
| 2017 | 435 | 10,373 | 76 | 1.38 | $424,893 | $120,533 |
| 2016 | 362 | 5,643 | 76 | 1.50 | $320,030 | $89,549 |
| 2015 | 292 | 4,344 | 75 | 1.39 | $231,760 | $65,047 |
| 2014 | 346 | 5,000 | 75 | 1.28 | $299,541 | $86,424 |
| 2013 | 349 | 3,850 | 74 | 1.28 | $290,812 | $82,813 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Botox | 20 | $35,869 | None |
| Return visit (30+ min) | 172 | $31,135 | $110 |
| New patient visit (45+ min) | 91 | $13,648 | $150 |
| Long return visit (40+ min) | 55 | $9,710 | $154 |
| Short return visit (20+ min) | 57 | $5,337 | $77 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 12 | $3,974 | $137 |
| Muscle electrical test | 23 | $2,784 | $103 |
| Nerve test | 17 | $2,213 | $130 |
| New patient visit (60+ min) | 12 | $2,205 | $184 |
| Muscle electrical test | 18 | $1,648 | $66 |
2022: 10 services
| Botox | 19 | $43,642 | None |
| Return visit (30+ min) | 179 | $32,553 | $112 |
| Long return visit (40+ min) | 63 | $12,254 | $155 |
| New patient visit (45+ min) | 73 | $10,696 | $147 |
| Short return visit (20+ min) | 63 | $5,529 | $77 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 11 | $5,200 | $137 |
| New patient visit (60+ min) | 16 | $2,927 | $183 |
| Muscle electrical test | 18 | $2,377 | $103 |
| Nerve test | 15 | $2,066 | $138 |
| Muscle electrical test | 22 | $1,977 | $71 |
2021: 12 services
| Botox | 19 | $44,860 | None |
| Return visit (30+ min) | 155 | $29,566 | $113 |
| Long return visit (40+ min) | 75 | $15,737 | $167 |
| New patient visit (45+ min) | 78 | $11,745 | $151 |
| New patient visit (60+ min) | 32 | $6,488 | $203 |
| Short return visit (20+ min) | 59 | $5,821 | $80 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 12 | $4,627 | $136 |
| Nerve test | 17 | $2,546 | $150 |
| Muscle electrical test | 22 | $2,410 | $69 |
| Muscle electrical test | 19 | $2,391 | $104 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $707 | $51 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 11 | $405 | $31 |
2020: 12 services
| Botox | 17 | $41,301 | None |
| Return visit (30+ min) | 127 | $15,903 | $92 |
| New patient visit (45+ min) | 76 | $11,504 | $151 |
| Short return visit (20+ min) | 86 | $6,380 | $56 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 13 | $4,876 | $128 |
| Long return visit (40+ min) | 26 | $3,334 | $128 |
| Nerve test | 12 | $3,184 | $265 |
| New patient visit (60+ min) | 16 | $3,156 | $197 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $2,704 | $69 |
| Muscle electrical test | 18 | $2,406 | $100 |
| Nerve test | 13 | $1,776 | $137 |
| Muscle electrical test | 16 | $1,596 | $67 |
2019: 9 services
| Botox | 22 | $53,849 | None |
| Return visit (30+ min) | 198 | $27,879 | $92 |
| New patient visit (45+ min) | 126 | $18,359 | $146 |
| Short return visit (20+ min) | 107 | $8,966 | $61 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 17 | $6,265 | $128 |
| Long return visit (40+ min) | 36 | $4,550 | $126 |
| Nerve test | 16 | $3,971 | $248 |
| Muscle electrical test | 20 | $2,655 | $92 |
| Muscle electrical test | 20 | $1,924 | $64 |
2018: 10 services
| Botox | 27 | $61,230 | None |
| Return visit (30+ min) | 174 | $23,964 | $90 |
| New patient visit (45+ min) | 149 | $20,834 | $140 |
| Short return visit (20+ min) | 117 | $9,697 | $58 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 17 | $5,556 | $123 |
| Long return visit (40+ min) | 40 | $5,144 | $129 |
| Nerve test | 17 | $2,525 | $149 |
| Muscle electrical test | 14 | $1,658 | $87 |
| Muscle electrical test | 18 | $1,403 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $981 | $61 |
2017: 10 services
| Botox | 18 | $42,705 | None |
| New patient visit (45+ min) | 152 | $21,555 | $142 |
| Return visit (30+ min) | 148 | $18,966 | $86 |
| Short return visit (20+ min) | 118 | $9,991 | $57 |
| Long return visit (40+ min) | 41 | $5,005 | $122 |
| Muscle electrical test | 14 | $1,993 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,587 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,425 | $65 |
| New patient visit (30+ min) | 15 | $1,270 | $85 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $1,083 | $35 |
2016: 11 services
| Botox | 12 | $20,063 | None |
| Return visit (30+ min) | 122 | $17,325 | $90 |
| New patient visit (45+ min) | 99 | $13,727 | $139 |
| Short return visit (20+ min) | 92 | $7,772 | $62 |
| Long return visit (40+ min) | 41 | $5,218 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,789 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,865 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,822 | $121 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,186 | $34 |
| Muscle electrical test | 11 | $1,083 | $90 |
| Muscle electrical test | 11 | $896 | $60 |
2015: 9 services
| Return visit (30+ min) | 103 | $11,724 | $89 |
| New patient visit (45+ min) | 74 | $10,469 | $141 |
| Long return visit (40+ min) | 39 | $5,047 | $129 |
| Short return visit (20+ min) | 60 | $5,028 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,847 | $190 |
| Muscle electrical test | 17 | $1,967 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,630 | $65 |
| Nerve test | 12 | $1,428 | $119 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $693 | $36 |
2014: 11 services
| New patient visit (45+ min) | 122 | $17,249 | $141 |
| Return visit (30+ min) | 97 | $14,711 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,216 | $180 |
| Short return visit (20+ min) | 63 | $5,069 | $56 |
| Nerve test | 16 | $4,007 | $250 |
| Long return visit (40+ min) | 33 | $3,892 | $118 |
| Muscle electrical test | 21 | $2,599 | $90 |
| Nerve test | 14 | $1,779 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,729 | $64 |
| Muscle electrical test | 16 | $1,293 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $902 | $35 |
2013: 12 services
| New patient visit (45+ min) | 154 | $21,862 | $142 |
| Return visit (30+ min) | 104 | $14,638 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,619 | $170 |
| Nerve test | 16 | $4,616 | $288 |
| Short return visit (20+ min) | 48 | $4,064 | $62 |
| Nerve test | 15 | $3,203 | $214 |
| Long return visit (40+ min) | 22 | $2,576 | $117 |
| Muscle electrical test | 19 | $2,341 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,122 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,912 | $112 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $1,078 | $31 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $989 | $90 |
Drugs they prescribed that Part D paid
$219,711
Pharmacies billed $219,711 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (36 of 1,753) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
1,620 generic and 104 brand-name prescriptions · $219,711 in drug cost · 51 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rytary | Parkinson's | 14 | $33,843 | $2,417 |
| Nurtec Odt | None | 19 | $31,642 | $1,665 |
| Eliquis | None | 14 | $15,433 | $1,102 |
| Aimovig | Migraine | 12 | $8,563 | $714 |
| Carbidopa-Levodopa | None | 167 | $6,083 | $36 |
See all 45 drugs
| Rytary | Parkinson's | 14 | $33,843 | $2,417 |
| Nurtec Odt | None | 19 | $31,642 | $1,665 |
| Eliquis | None | 14 | $15,433 | $1,102 |
| Aimovig | Migraine | 12 | $8,563 | $714 |
| Carbidopa-Levodopa | None | 167 | $6,083 | $36 |
| Gabapentin | None | 193 | $4,931 | $26 |
| Carbamazepine Er | None | 21 | $4,433 | $211 |
| Oxcarbazepine | None | 39 | $4,023 | $103 |
| Escitalopram | None | 116 | $3,620 | $31 |
| Dimethyl | None | 11 | $2,004 | $182 |
| Droxidopa | None | 12 | $1,987 | $166 |
| Memantine | None | 48 | $1,903 | $40 |
| Levetiracetam | None | 49 | $1,889 | $39 |
| Quetiapine | None | 38 | $1,873 | $49 |
| Lacosamide | None | 22 | $1,566 | $71 |
| Carbidopa-Levodopa Er | None | 33 | $1,501 | $45 |
| Divalproex | None | 32 | $1,391 | $43 |
| Ropinirole | None | 32 | $1,314 | $41 |
| Donepezil | None | 90 | $1,073 | $12 |
| Pregabalin | None | 33 | $1,027 | $31 |
| Olanzapine | None | 12 | $965 | $80 |
| Promethegan | None | 12 | $926 | $77 |
| Phenobarbital | None | 29 | $786 | $27 |
| Lamotrigine | None | 38 | $754 | $20 |
| Primidone | None | 28 | $727 | $26 |
| Promethazine | None | 42 | $606 | $14 |
| Hydrocodone-Acetaminophen | None | 24 | $542 | $23 |
| Pramipexole Dihydrochloride | None | 11 | $503 | $46 |
| Amantadine | None | 23 | $479 | $21 |
| Topiramate | None | 38 | $362 | $10 |
| Atorvastatin | None | 17 | $356 | $21 |
| Divalproex Sodium Er | None | 11 | $293 | $27 |
| Propranolol | None | 16 | $258 | $16 |
| Clopidogrel | None | 13 | $249 | $19 |
| Clonazepam | None | 19 | $238 | $13 |
| Duloxetine | None | 11 | $201 | $18 |
| Cyclobenzaprine | None | 12 | $177 | $15 |
| Tizanidine | None | 16 | $173 | $11 |
| Mirtazapine | None | 13 | $152 | $12 |
| Rizatriptan | None | 18 | $122 | $7 |
| Zolpidem | None | 22 | $122 | $6 |
| Diazepam | None | 22 | $116 | $5 |
| Prednisone | None | 17 | $74 | $4 |
| Lorazepam | None | 16 | $72 | $4 |
| Trazodone | None | 11 | $50 | $5 |
Year by year
| 2024 | 1,753 | 290 | 2% (36) | 6% | $219,711 |
| 2023 | 1,701 | 283 | 3% (46) | 7% | $294,854 |
| 2022 | 1,726 | 276 | 3% (54) | None | $251,417 |
| 2021 | 1,819 | 286 | 3% (61) | None | $298,267 |
| 2020 | 1,733 | 293 | 4% (64) | None | $254,415 |
| 2019 | 1,825 | 303 | 4% (72) | None | $429,337 |
| 2018 | 1,782 | 271 | 3% (56) | None | $480,648 |
| 2017 | 1,591 | 246 | 1% (16) | None | $654,066 |
| 2016 | 1,418 | 224 | 2% (27) | 8% | $314,162 |
| 2015 | 1,164 | 175 | 2% (27) | 11% | $86,431 |
| 2014 | 1,046 | 157 | 3% (35) | None | $72,954 |
| 2013 | 727 | 128 | 3% (22) | None | $45,492 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 48 drugs
| Rytary | Parkinson's | 26 | $61,799 | $2,377 |
| Nurtec Odt | None | 19 | $29,233 | $1,539 |
| Aptiom | None | 11 | $25,355 | $2,305 |
| Eliquis | None | 13 | $17,348 | $1,334 |
| Carbidopa-Levodopa | None | 147 | $10,304 | $70 |
| Aimovig | Migraine | 12 | $9,886 | $824 |
| Droxidopa | None | 11 | $7,960 | $724 |
| Dimethyl | None | 13 | $7,097 | $546 |
| Carbamazepine Er | None | 21 | $6,389 | $304 |
| Memantine | None | 66 | $5,970 | $90 |
| Gabapentin | None | 181 | $5,783 | $32 |
| Oxcarbazepine | None | 40 | $4,616 | $115 |
| Donepezil | None | 118 | $2,334 | $20 |
| Carbamazepine | None | 17 | $2,176 | $128 |
| Escitalopram | None | 113 | $1,832 | $16 |
| Lamotrigine | None | 33 | $1,675 | $51 |
| Levetiracetam | None | 42 | $1,602 | $38 |
| Phenobarbital | None | 15 | $1,456 | $97 |
| Divalproex | None | 26 | $1,290 | $50 |
| Quetiapine | None | 33 | $1,147 | $35 |
| Pramipexole Dihydrochloride | None | 11 | $920 | $84 |
| Carbidopa-Levodopa Er | None | 15 | $906 | $60 |
| Baclofen | None | 15 | $897 | $60 |
| Ropinirole | None | 26 | $730 | $28 |
| Promethazine | None | 35 | $725 | $21 |
| Pregabalin | None | 16 | $640 | $40 |
| Primidone | None | 41 | $620 | $15 |
| Nortriptyline | None | 16 | $615 | $38 |
| Dalfampridine Er | None | 12 | $537 | $45 |
| Atorvastatin | None | 28 | $470 | $17 |
| Duloxetine | None | 17 | $440 | $26 |
| Topiramate | None | 33 | $429 | $13 |
| Cyclobenzaprine | None | 16 | $348 | $22 |
| Zolpidem | None | 15 | $342 | $23 |
| Rizatriptan | None | 14 | $337 | $24 |
| Propranolol | None | 13 | $333 | $26 |
| Risperidone | None | 11 | $317 | $29 |
| Trazodone | None | 24 | $307 | $13 |
| Hydrocodone-Acetaminophen | None | 25 | $300 | $12 |
| Metoprolol | None | 11 | $232 | $21 |
| Clonazepam | None | 21 | $230 | $11 |
| Amlodipine Besylate | None | 11 | $208 | $19 |
| Lisinopril | None | 11 | $203 | $18 |
| Sumatriptan | None | 18 | $152 | $8 |
| Tizanidine | None | 16 | $144 | $9 |
| Diazepam | None | 18 | $117 | $6 |
| Mirtazapine | None | 12 | $70 | $6 |
| Oxycodone | None | 11 | $22 | $2 |
2022: 40 drugs
| Rytary | Parkinson's | 30 | $61,967 | $2,066 |
| Eliquis | None | 18 | $15,778 | $877 |
| Carbidopa-Levodopa | None | 183 | $10,861 | $59 |
| Aimovig | Migraine | 12 | $9,732 | $811 |
| Gabapentin | None | 147 | $7,057 | $48 |
| Dimethyl | None | 11 | $5,995 | $545 |
| Carbamazepine Er | None | 22 | $5,969 | $271 |
| Memantine | None | 95 | $5,291 | $56 |
| Oxcarbazepine | None | 34 | $3,314 | $97 |
| Divalproex | None | 22 | $2,348 | $107 |
| Pregabalin | None | 34 | $2,125 | $63 |
| Carbidopa-Levodopa Er | None | 31 | $1,939 | $63 |
| Donepezil | None | 137 | $1,693 | $12 |
| Dalfampridine Er | None | 12 | $1,676 | $140 |
| Escitalopram | None | 103 | $1,570 | $15 |
| Quetiapine | None | 32 | $1,345 | $42 |
| Amantadine | None | 17 | $1,343 | $79 |
| Levetiracetam | None | 27 | $1,307 | $48 |
| Pramipexole Dihydrochloride | None | 20 | $892 | $45 |
| Clonazepam | None | 32 | $877 | $27 |
| Ropinirole | None | 30 | $865 | $29 |
| Baclofen | None | 11 | $860 | $78 |
| Topiramate | None | 44 | $849 | $19 |
| Lamotrigine | None | 24 | $823 | $34 |
| Primidone | None | 26 | $801 | $31 |
| Nortriptyline | None | 21 | $443 | $21 |
| Promethazine | None | 53 | $434 | $8 |
| Propranolol | None | 12 | $427 | $36 |
| Atorvastatin | None | 20 | $365 | $18 |
| Rizatriptan | None | 20 | $312 | $16 |
| Trazodone | None | 31 | $271 | $9 |
| Cyclobenzaprine | None | 20 | $257 | $13 |
| Hydrocodone-Acetaminophen | None | 26 | $246 | $9 |
| Sumatriptan | None | 18 | $184 | $10 |
| Mirtazapine | None | 18 | $181 | $10 |
| Butalbital-Acetaminophen-Caffe | None | 18 | $176 | $10 |
| Sertraline | None | 14 | $164 | $12 |
| Zolpidem | None | 15 | $107 | $7 |
| Diazepam | None | 13 | $98 | $8 |
| Oxycodone | None | 13 | $93 | $7 |
2021: 38 drugs
| Rytary | Parkinson's | 27 | $42,362 | $1,569 |
| Dimethyl | None | 13 | $21,820 | $1,678 |
| Vimpat | None | 18 | $14,346 | $797 |
| Carbidopa-Levodopa | None | 195 | $13,177 | $68 |
| Aimovig | Migraine | 14 | $10,136 | $724 |
| Divalproex | None | 18 | $7,923 | $440 |
| Memantine | None | 142 | $7,738 | $54 |
| Gabapentin | None | 192 | $6,424 | $33 |
| Carbamazepine Er | None | 21 | $6,284 | $299 |
| Carbidopa-Levodopa Er | None | 40 | $3,157 | $79 |
| Oxcarbazepine | None | 27 | $3,001 | $111 |
| Levetiracetam | None | 43 | $2,017 | $47 |
| Amantadine | None | 19 | $1,828 | $96 |
| Pregabalin | None | 32 | $1,693 | $53 |
| Donepezil | None | 106 | $1,250 | $12 |
| Topiramate | None | 58 | $1,193 | $21 |
| Clonazepam | None | 35 | $1,119 | $32 |
| Ropinirole | None | 23 | $1,049 | $46 |
| Escitalopram | None | 83 | $952 | $11 |
| Quetiapine | None | 43 | $776 | $18 |
| Primidone | None | 24 | $772 | $32 |
| Lamotrigine | None | 25 | $634 | $25 |
| Nortriptyline | None | 21 | $463 | $22 |
| Propranolol | None | 20 | $434 | $22 |
| Trazodone | None | 57 | $408 | $7 |
| Promethazine | None | 46 | $403 | $9 |
| Atorvastatin | None | 21 | $352 | $17 |
| Sumatriptan | None | 21 | $348 | $17 |
| Rizatriptan | None | 17 | $292 | $17 |
| Risperidone | None | 14 | $267 | $19 |
| Hydrocodone-Acetaminophen | None | 27 | $241 | $9 |
| Cyclobenzaprine | None | 12 | $208 | $17 |
| Tizanidine | None | 14 | $187 | $13 |
| Sertraline | None | 29 | $160 | $6 |
| Oxycodone | None | 13 | $93 | $7 |
| Zolpidem | None | 12 | $86 | $7 |
| Diazepam | None | 12 | $81 | $7 |
| Lorazepam | None | 11 | $14 | $1 |
2020: 39 drugs
| Rytary | Parkinson's | 13 | $25,262 | $1,943 |
| Vimpat | None | 11 | $12,812 | $1,165 |
| Carbidopa-Levodopa | None | 177 | $12,618 | $71 |
| Gabapentin | None | 212 | $5,890 | $28 |
| Memantine | None | 108 | $5,885 | $54 |
| Carbamazepine Er | None | 16 | $5,700 | $356 |
| Divalproex | None | 16 | $4,753 | $297 |
| Carbidopa-Levodopa Er | None | 69 | $4,433 | $64 |
| Carbamazepine | None | 13 | $2,322 | $179 |
| Levetiracetam | None | 53 | $1,951 | $37 |
| Pregabalin | None | 25 | $1,844 | $74 |
| Oxcarbazepine | None | 16 | $1,838 | $115 |
| Clonazepam | None | 47 | $1,729 | $37 |
| Amantadine | None | 25 | $1,621 | $65 |
| Donepezil | None | 101 | $1,321 | $13 |
| Pyridostigmine | None | 11 | $1,044 | $95 |
| Baclofen | None | 14 | $1,040 | $74 |
| Venlafaxine Hcl Er | None | 14 | $784 | $56 |
| Atorvastatin | None | 35 | $710 | $20 |
| Escitalopram | None | 54 | $647 | $12 |
| Lamotrigine | None | 22 | $632 | $29 |
| Topiramate | None | 33 | $623 | $19 |
| Dextroamphetamine-Amphetamine | None | 11 | $562 | $51 |
| Quetiapine | None | 37 | $529 | $14 |
| Cyclobenzaprine | None | 26 | $428 | $16 |
| Fluoxetine | None | 12 | $396 | $33 |
| Sumatriptan | None | 26 | $318 | $12 |
| Trazodone | None | 35 | $313 | $9 |
| Methylphenidate | None | 20 | $287 | $14 |
| Tizanidine | None | 13 | $237 | $18 |
| Sertraline | None | 18 | $228 | $13 |
| Duloxetine | None | 15 | $223 | $15 |
| Promethazine | None | 27 | $201 | $7 |
| Methadone | None | 11 | $172 | $16 |
| Hydrocodone-Acetaminophen | None | 21 | $150 | $7 |
| Zolpidem | None | 15 | $116 | $8 |
| Oxycodone | None | 16 | $114 | $7 |
| Tramadol | None | 11 | $87 | $8 |
| Diazepam | None | 11 | $65 | $6 |
2019: 39 drugs
| Tecfidera | None | 12 | $98,758 | $8,230 |
| Vimpat | None | 23 | $26,308 | $1,144 |
| Lyrica | None | 34 | $21,491 | $632 |
| Rytary | Parkinson's | 12 | $14,378 | $1,198 |
| Carbidopa-Levodopa | None | 192 | $11,778 | $61 |
| Sumatriptan | None | 30 | $6,386 | $213 |
| Linzess | None | 13 | $5,538 | $426 |
| Gabapentin | None | 221 | $5,228 | $24 |
| Memantine | None | 96 | $4,995 | $52 |
| Divalproex | None | 28 | $4,893 | $175 |
| Carbamazepine | None | 20 | $3,361 | $168 |
| Carbidopa-Levodopa Er | None | 41 | $3,056 | $75 |
| Carbamazepine Er | None | 13 | $2,378 | $183 |
| Clonazepam | None | 57 | $2,017 | $35 |
| Levetiracetam | None | 52 | $1,807 | $35 |
| Oxcarbazepine | None | 18 | $1,708 | $95 |
| Donepezil | None | 86 | $1,269 | $15 |
| Duloxetine | None | 45 | $1,078 | $24 |
| Propranolol | None | 14 | $909 | $65 |
| Baclofen | None | 25 | $860 | $34 |
| Topiramate | None | 55 | $760 | $14 |
| Atorvastatin | None | 32 | $758 | $24 |
| Risperidone | None | 17 | $671 | $39 |
| Lamotrigine | None | 32 | $559 | $17 |
| Quetiapine | None | 38 | $508 | $13 |
| Escitalopram | None | 32 | $430 | $13 |
| Tizanidine | None | 32 | $424 | $13 |
| Sertraline | None | 39 | $403 | $10 |
| Hydrocodone-Acetaminophen | None | 30 | $328 | $11 |
| Methadone | None | 19 | $317 | $17 |
| Methylphenidate | None | 15 | $278 | $19 |
| Trazodone | None | 30 | $248 | $8 |
| Zonisamide | None | 20 | $238 | $12 |
| Pantoprazole | None | 12 | $233 | $19 |
| Glipizide | None | 12 | $204 | $17 |
| Promethazine | None | 23 | $164 | $7 |
| Oxycodone | None | 15 | $107 | $7 |
| Zolpidem | None | 13 | $93 | $7 |
| Buspirone | None | 12 | $80 | $7 |
2018: 46 drugs
| Privigen | Immune globulin | 25 | $254,022 | $10,161 |
| Ampyra | None | 11 | $29,682 | $2,698 |
| Vimpat | None | 28 | $25,462 | $909 |
| Carbidopa-Levodopa | None | 192 | $13,111 | $68 |
| Lyrica | None | 24 | $12,561 | $523 |
| Entacapone | None | 12 | $9,922 | $827 |
| Divalproex | None | 26 | $5,155 | $198 |
| Memantine | None | 68 | $4,491 | $66 |
| Gabapentin | None | 177 | $4,258 | $24 |
| Carbidopa-Levodopa Er | None | 51 | $3,491 | $68 |
| Sumatriptan | None | 12 | $3,107 | $259 |
| Carbamazepine | None | 21 | $2,469 | $118 |
| Levetiracetam | None | 76 | $1,978 | $26 |
| Oxcarbazepine | None | 26 | $1,779 | $68 |
| Donepezil | None | 105 | $1,382 | $13 |
| Tizanidine | None | 22 | $1,216 | $55 |
| Clonazepam | None | 50 | $1,196 | $24 |
| Baclofen | None | 27 | $910 | $34 |
| Sumatriptan | None | 32 | $724 | $23 |
| Duloxetine | None | 12 | $680 | $57 |
| Venlafaxine Hcl Er | None | 21 | $594 | $28 |
| Topiramate | None | 44 | $511 | $12 |
| Pramipexole Dihydrochloride | None | 11 | $499 | $45 |
| Sertraline | None | 41 | $476 | $12 |
| Propranolol | None | 16 | $469 | $29 |
| Atorvastatin | None | 22 | $465 | $21 |
| Primidone | None | 23 | $422 | $18 |
| Quetiapine | None | 35 | $378 | $11 |
| Naproxen | None | 13 | $367 | $28 |
| Escitalopram | None | 26 | $342 | $13 |
| Lamotrigine | None | 33 | $332 | $10 |
| Mirtazapine | None | 14 | $293 | $21 |
| Zonisamide | None | 20 | $268 | $13 |
| Pantoprazole | None | 12 | $262 | $22 |
| Levothyroxine | None | 20 | $255 | $13 |
| Methadone | None | 15 | $188 | $13 |
| Promethazine | None | 26 | $186 | $7 |
| Clopidogrel | None | 15 | $157 | $10 |
| Hydrocodone-Acetaminophen | None | 21 | $142 | $7 |
| Citalopram Hbr | None | 11 | $109 | $10 |
| Nortriptyline | None | 11 | $109 | $10 |
| Trazodone | None | 12 | $94 | $8 |
| Oxycodone | None | 13 | $93 | $7 |
| Zolpidem | None | 12 | $86 | $7 |
| Diazepam | None | 13 | $73 | $6 |
| Lorazepam | None | 12 | $30 | $3 |
2017: 38 drugs
| Privigen | Immune globulin | 26 | $429,892 | $16,534 |
| Avonex | None | 12 | $75,821 | $6,318 |
| Ampyra | None | 14 | $31,355 | $2,240 |
| Vimpat | None | 30 | $24,577 | $819 |
| Carbidopa-Levodopa | None | 205 | $9,820 | $48 |
| Lyrica | None | 17 | $8,325 | $490 |
| Divalproex | None | 27 | $5,917 | $219 |
| Memantine | None | 83 | $4,558 | $55 |
| Gabapentin | None | 152 | $3,624 | $24 |
| Carbidopa-Levodopa Er | None | 55 | $3,104 | $56 |
| Oxcarbazepine | None | 33 | $2,584 | $78 |
| Carbamazepine Er | None | 13 | $2,401 | $185 |
| Levetiracetam | None | 68 | $1,715 | $25 |
| Donepezil | None | 114 | $1,528 | $13 |
| Duloxetine | None | 27 | $1,278 | $47 |
| Baclofen | None | 17 | $867 | $51 |
| Divalproex Sodium Er | None | 13 | $840 | $65 |
| Sumatriptan | None | 16 | $686 | $43 |
| Propranolol | None | 15 | $644 | $43 |
| Atorvastatin | None | 34 | $553 | $16 |
| Venlafaxine Hcl Er | None | 20 | $529 | $26 |
| Mirtazapine | None | 26 | $505 | $19 |
| Sertraline | None | 40 | $408 | $10 |
| Pantoprazole | None | 17 | $401 | $24 |
| Clonazepam | None | 33 | $399 | $12 |
| Pramipexole Dihydrochloride | None | 16 | $383 | $24 |
| Primidone | None | 30 | $350 | $12 |
| Topiramate | None | 28 | $334 | $12 |
| Quetiapine | None | 34 | $324 | $10 |
| Clopidogrel | None | 17 | $263 | $15 |
| Lovastatin | None | 12 | $243 | $20 |
| Rizatriptan | None | 11 | $240 | $22 |
| Naproxen | None | 11 | $184 | $17 |
| Levothyroxine | None | 11 | $137 | $12 |
| Citalopram Hbr | None | 29 | $125 | $4 |
| Lamotrigine | None | 11 | $102 | $9 |
| Promethazine | None | 12 | $84 | $7 |
| Zolpidem | None | 12 | $59 | $5 |
2016: 33 drugs
| Vimpat | 27 | $23,537 | $872 |
| Namenda Xr | 19 | $13,167 | $693 |
| Lyrica | 18 | $8,055 | $447 |
| Carbidopa-Levodopa | 185 | $5,551 | $30 |
| Memantine | 81 | $5,105 | $63 |
| Divalproex | 16 | $5,050 | $316 |
| Gabapentin | 140 | $4,308 | $31 |
| Humalog | 11 | $2,931 | $266 |
| Oxcarbazepine | 33 | $2,455 | $74 |
| Carbamazepine Er | 11 | $1,795 | $163 |
| Carbidopa-Levodopa Er | 36 | $1,683 | $47 |
| Donepezil | 112 | $1,600 | $14 |
| Levetiracetam | 82 | $1,475 | $18 |
| Duloxetine | 32 | $1,183 | $37 |
| Pramipexole Dihydrochloride | 27 | $1,098 | $41 |
| Atorvastatin | 60 | $873 | $15 |
| Ropinirole | 15 | $463 | $31 |
| Topiramate | 31 | $456 | $15 |
| Clopidogrel | 23 | $413 | $18 |
| Hydrocodone-Acetaminophen | 12 | $342 | $29 |
| Sumatriptan | 14 | $288 | $21 |
| Mirtazapine | 19 | $280 | $15 |
| Nortriptyline | 22 | $279 | $13 |
| Sertraline | 33 | $259 | $8 |
| Clonazepam | 23 | $239 | $10 |
| Primidone | 26 | $228 | $9 |
| Quetiapine | 15 | $164 | $11 |
| Amitriptyline | 13 | $158 | $12 |
| Pantoprazole | 16 | $147 | $9 |
| Baclofen | 11 | $140 | $13 |
| Lovastatin | 11 | $90 | $8 |
| Citalopram Hbr | 18 | $83 | $5 |
| Lorazepam | 12 | $49 | $4 |
2015: 32 drugs
| Vimpat | 18 | $12,949 | $719 |
| Exelon | 11 | $10,042 | $913 |
| Namenda | 26 | $7,386 | $284 |
| Carbidopa-Levodopa | 157 | $6,733 | $43 |
| Lyrica | 12 | $4,720 | $393 |
| Duloxetine | 31 | $3,324 | $107 |
| Gabapentin | 124 | $3,211 | $26 |
| Humalog | 11 | $2,576 | $234 |
| Memantine | 14 | $2,066 | $148 |
| Amantadine | 12 | $1,692 | $141 |
| Pramipexole Dihydrochloride | 26 | $1,485 | $57 |
| Carbidopa-Levodopa Er | 28 | $1,398 | $50 |
| Oxcarbazepine | 27 | $1,219 | $45 |
| Donepezil | 93 | $1,100 | $12 |
| Levetiracetam | 44 | $896 | $20 |
| Topiramate | 31 | $428 | $14 |
| Atorvastatin | 36 | $408 | $11 |
| Hydrocodone-Acetaminophen | 14 | $311 | $22 |
| Sertraline | 40 | $284 | $7 |
| Clopidogrel | 20 | $284 | $14 |
| Quetiapine | 20 | $269 | $13 |
| Tizanidine | 17 | $252 | $15 |
| Amlodipine Besylate | 21 | $216 | $10 |
| Ropinirole | 11 | $164 | $15 |
| Clonazepam | 15 | $154 | $10 |
| Lorazepam | 25 | $151 | $6 |
| Nortriptyline | 12 | $146 | $12 |
| Sumatriptan | 13 | $145 | $11 |
| Primidone | 12 | $123 | $10 |
| Pantoprazole | 14 | $110 | $8 |
| Citalopram Hbr | 12 | $90 | $8 |
| Trazodone | 11 | $62 | $6 |
2014: 26 drugs
| Vimpat | 15 | $10,448 | $697 |
| Namenda | 36 | $8,366 | $232 |
| Carbidopa-Levodopa | 133 | $7,852 | $59 |
| Lyrica | 19 | $6,552 | $345 |
| Duloxetine | 18 | $2,722 | $151 |
| Gabapentin | 108 | $1,943 | $18 |
| Amantadine | 13 | $1,533 | $118 |
| Levetiracetam | 53 | $1,419 | $27 |
| Carbidopa-Levodopa Er | 42 | $1,350 | $32 |
| Topiramate | 22 | $708 | $32 |
| Donepezil | 52 | $677 | $13 |
| Quetiapine | 31 | $504 | $16 |
| Carisoprodol | 16 | $491 | $31 |
| Pramipexole Dihydrochloride | 12 | $471 | $39 |
| Oxycodone | 12 | $424 | $35 |
| Sertraline | 42 | $344 | $8 |
| Hydrocodone-Acetaminophen | 15 | $319 | $21 |
| Atorvastatin | 17 | $299 | $18 |
| Clopidogrel | 21 | $268 | $13 |
| Lorazepam | 42 | $238 | $6 |
| Amlodipine Besylate | 22 | $228 | $10 |
| Sumatriptan | 14 | $164 | $12 |
| Simvastatin | 14 | $152 | $11 |
| Propranolol | 13 | $125 | $10 |
| Clonazepam | 14 | $119 | $9 |
| Trazodone | 16 | $71 | $4 |
2013: 18 drugs
| Namenda | 43 | $10,114 | $235 |
| Carbidopa-Levodopa | 117 | $6,244 | $53 |
| Lyrica | 18 | $4,261 | $237 |
| Clopidogrel | 20 | $1,452 | $73 |
| Carbidopa-Levodopa Er | 26 | $1,443 | $55 |
| Levetiracetam | 28 | $1,135 | $41 |
| Donepezil | 45 | $931 | $21 |
| Gabapentin | 39 | $705 | $18 |
| Pramipexole Dihydrochloride | 15 | $557 | $37 |
| Topiramate | 19 | $555 | $29 |
| Quetiapine | 27 | $408 | $15 |
| Sertraline | 35 | $378 | $11 |
| Simvastatin | 14 | $188 | $13 |
| Lorazepam | 28 | $182 | $7 |
| Hydrocodone-Acetaminophen | 13 | $178 | $14 |
| Primidone | 17 | $158 | $9 |
| Promethazine | 12 | $84 | $7 |
| Amitriptyline | 12 | $68 | $6 |
Money from drug and device companies
$14 in 2024
| 2024 | 1 | 1 | None | $14 |
| 2023 | 1 | 2 | None | $30 |
| 2022 | 1 | 1 | None | $21 |
| 2020 | 1 | 1 | None | $13 |
| 2019 | 3 | 4 | None | $520 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Ubrelvy | $14 | 1 payment
|
See the published payment
| Abbvie | Meals · 2024-06-14 | Ubrelvy | $14 |
See earlier years (2023, 2022, 2020, 2019)
2023: $30
| Impel Pharmaceuticals | Trudhesa | $30 | 2 payments
|
2022: $21
| GE HealthCare | None | $21 | 1 payment
|
2020: $13
| Allergan | Avycaz | $13 | 1 payment
|
2019: $520
| Genentech | Venclexta | $478 | 2 payments
|
| Ucb | Briviact | $26 | 1 payment
|
| Lilly USA | Emgality | $17 | 1 payment
|
Professional record
- NPI
- 1629108717
- Licence
- CA A98828California A98828: Current · expires 2027-02-28
- Trained
- Harvard Medical School, 2005
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-03-07
- NPI last updated
- 2011-12-13
This is when the NPI record was last certified, not a medical board exam.